New Vaccine Protects Against Staph, Drug-Resistant MRSA

A new vaccine developed by researchers at the University of Iowa in Iowa City protects patients against lethal pneumonia caused by Staphylococcus aureus bacteria and drug-resistant Methicillin-resistant Staphylococcus aureus, according to a news release from the University of Iowa.

Advertisement

Researchers using an animal model found vaccination against three staph toxins almost completely protect against staph infections. Additionally, after introducing the vaccine, disease-causing bacteria were completely eliminated from the animal’s lungs.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

Previous attempts to target staph vaccines have focused on the cell-surface proteins on bacteria instead of staph toxins, according to the report. Researchers found vaccines focused on cell-surface proteins tend to increase the severity of the infection while the newly developed vaccine that targets staph toxins almost completely protects against staph infections.

More Articles on HAIs:

10 Hand Hygiene Posters to Hang in Your Facility
Many Treated for C. diff Not Actually Infected
Hospital Compare Adds C. diff, MRSA Data

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.